Latest Ratios: P/E Ratio 69.7x · EV/EBITDA 51.6x · ROE 71.7%. (1997–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $15.0B | $10.6B | $16.8B | $13.5B | $7.7B | $10.0B | $6.8B | $5.2B | $2.8B | $3.4B | $3.8B |
| Enterprise Value | $14.7B | $10.4B | $16.6B | $13.2B | $7.5B | $9.8B | $6.6B | $5.1B | $2.7B | $3.3B | $3.7B |
| P/E Ratio → | 69.72 | 48.14 | 76.99 | 76.35 | 59.80 | 90.40 | 77.34 | 60.42 | 26.82 | 29.49 | 30.83 |
| P/S Ratio | 12.93 | 9.78 | 16.12 | 14.52 | 10.04 | 15.07 | 11.54 | 8.40 | 5.03 | 5.78 | 6.32 |
| P/B Ratio | 49.03 | 33.62 | 56.18 | 48.44 | 33.94 | 39.90 | 30.91 | 36.49 | 19.13 | 19.66 | 22.56 |
| P/FCF | 39.40 | 28.29 | 58.69 | 55.82 | 44.48 | 55.21 | 48.98 | 39.42 | 21.65 | 21.79 | 28.84 |
| P/OCF | 38.40 | 27.17 | 56.96 | 54.75 | 42.85 | 54.01 | 48.03 | 35.34 | 20.49 | 20.96 | 27.42 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 9.58 | 15.91 | 14.24 | 9.76 | 14.71 | 11.24 | 8.28 | 4.86 | 5.57 | 6.16 |
| EV / EBITDA | 51.56 | 35.86 | 61.91 | 61.34 | 46.98 | 68.62 | 53.57 | 41.27 | 19.06 | 17.02 | 18.32 |
| EV / EBIT | 52.13 | 36.25 | 62.16 | 61.91 | 47.35 | 72.80 | 57.77 | 44.11 | 20.28 | 17.57 | 19.00 |
| EV / FCF | — | 27.71 | 57.93 | 54.78 | 43.26 | 53.88 | 47.70 | 38.82 | 20.88 | 20.99 | 28.12 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 55.7% | 55.7% | 54.2% | 53.0% | 52.4% | 53.9% | 52.4% | 52.6% | 55.4% | 57.1% | 57.2% |
| Operating Margin | 26.1% | 26.1% | 25.1% | 22.6% | 19.9% | 20.2% | 19.5% | 18.8% | 23.9% | 31.2% | 32.1% |
| Net Profit Margin | 20.3% | 20.3% | 20.9% | 19.0% | 16.8% | 16.6% | 14.9% | 13.9% | 18.7% | 19.6% | 20.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 71.7% | 71.7% | 75.6% | 69.9% | 54.0% | 47.1% | 48.3% | 59.3% | 65.0% | 67.7% | 68.1% |
| ROA | 27.5% | 27.5% | 30.5% | 28.4% | 23.2% | 22.0% | 20.8% | 25.2% | 33.7% | 38.1% | 39.1% |
| ROIC | 236.8% | 236.8% | 370.5% | 774.8% | 898.3% | 386.5% | 161.3% | 155.2% | 206.1% | 226.1% | 193.2% |
| ROCE | 76.3% | 76.3% | 78.7% | 74.7% | 56.0% | 48.1% | 49.7% | 65.8% | 75.9% | 100.3% | 99.6% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.36 | 0.36 | 0.16 | 0.06 | 0.06 | 0.09 | 0.13 | 0.23 | — | — | — |
| Debt / EBITDA | 0.39 | 0.39 | 0.18 | 0.08 | 0.09 | 0.16 | 0.23 | 0.26 | — | — | — |
| Net Debt / Equity | — | -0.69 | -0.73 | -0.91 | -0.93 | -0.96 | -0.81 | -0.55 | -0.67 | -0.72 | -0.56 |
| Net Debt / EBITDA | -0.75 | -0.75 | -0.82 | -1.17 | -1.33 | -1.69 | -1.44 | -0.63 | -0.70 | -0.64 | -0.47 |
| Debt / FCF | — | -0.58 | -0.76 | -1.05 | -1.22 | -1.33 | -1.28 | -0.59 | -0.76 | -0.80 | -0.72 |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — |
Net cash position: cash ($329M) exceeds total debt ($112M)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.28 | 1.28 | 1.26 | 1.31 | 1.32 | 1.64 | 1.70 | 1.28 | 1.48 | 1.84 | 1.76 |
| Quick Ratio | 1.28 | 1.28 | 1.26 | 1.31 | 1.32 | 1.64 | 1.70 | 1.28 | 1.48 | 1.84 | 1.76 |
| Cash Ratio | 0.72 | 0.72 | 0.67 | 0.74 | 0.71 | 1.06 | 1.04 | 0.61 | 0.69 | 1.01 | 0.81 |
| Asset Turnover | — | 1.29 | 1.38 | 1.38 | 1.35 | 1.23 | 1.26 | 1.66 | 1.82 | 1.89 | 2.03 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 72.46 | 73.77 | 71.74 | 79.66 | 69.86 | 67.98 | 59.62 | 65.35 | 56.62 | 60.55 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 1.4% | 2.1% | 1.3% | 1.3% | 1.7% | 1.1% | 1.3% | 1.7% | 3.7% | 3.4% | 3.2% |
| FCF Yield | 2.5% | 3.5% | 1.7% | 1.8% | 2.2% | 1.8% | 2.0% | 2.5% | 4.6% | 4.6% | 3.5% |
| Buyback Yield | 2.1% | 3.0% | 1.7% | 1.5% | 2.7% | 1.2% | 0.6% | 2.3% | 5.3% | 3.8% | 4.4% |
| Total Shareholder Yield | 2.1% | 3.0% | 1.7% | 1.5% | 2.7% | 1.2% | 0.6% | 2.3% | 5.3% | 3.8% | 4.4% |
| Shares Outstanding | — | $61M | $62M | $63M | $63M | $64M | $64M | $65M | $66M | $69M | $72M |
Includes 30+ ratios · 29 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MANH stock.
Manhattan Associates, Inc.'s current P/E ratio is 69.7x. The historical average is 50.9x. This places it at the 75th percentile of its historical range.
Manhattan Associates, Inc.'s current EV/EBITDA is 51.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 28.5x.
Manhattan Associates, Inc.'s return on equity (ROE) is 71.7%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 37.3%.
Based on historical data, Manhattan Associates, Inc. is trading at a P/E of 69.7x. This is at the 75th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Manhattan Associates, Inc. has 55.7% gross margin and 26.1% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Manhattan Associates, Inc.'s Debt/EBITDA ratio is 0.4x, indicating low leverage. A ratio below 2x is generally considered financially healthy.
Key Metrics
Top Statement Risk
Buybacks eroding equity cushion
Metrics are mathematically derived from official filings.
Premium Multiple Embeds Cloud Compounding
At a trailing P/E of 65.0x and EV/EBITDA of 47.1x, Manhattan Associates trades at a pronounced premium to peers such as Veeva at 57.6x P/E and Paylocity at 34.6x, based on market pricing data compiled for this analysis.
The 42.6x forward P/E against 65.0x trailing implies the market is already pricing a meaningful earnings reacceleration, consistent with the 11.0% revenue growth logged in 2026Q3, yet the 3.02 PEG suggests the multiple presumes more than three years of above-trend growth. The 12.8x P/S also appears to reflect a best-of-breed WMS premium rather than a pure software multiple, which would be difficult to defend if the services-heavy mix keeps gross margin near 57% instead of the 70%+ typical of subscription peers. Given the recent EPS miss alongside record bookings, investors should monitor whether the valuation gap to Veeva (57.6x P/E, 41.5x EV/EBITDA) narrows through earnings catch-up or multiple compression.
ROIC Spikes on Shrinking Equity Base
MANH's ROIC reached 155.1% in 2026Q3 versus 47.0% in 2024Q4, a surge driven less by operating improvement than by the denominator effect of $844.6M of cumulative buybacks, according to the company's quarterly ratio disclosures over the period.
The reported ROIC of 155.1% far exceeds what net margin (20.0%) multiplied by asset turnover (0.42) would imply, which suggests the invested-capital base has been thinned by repurchases and possibly other adjustments rather than by a step-change in earning power; this warrants further investigation into how the metric is constructed. The widening gap between ROE (34.2%) and ROA (8.5%) in 2026Q3 confirms that leverage and equity reduction, not asset productivity, are doing most of the work, so the true compounding signal remains the stable 16.6%–24.6% ROE band rather than the headline ROIC. Against peers such as Paylocity (27.2% ROIC) and WMS (16.8% ROIC), MANH's reported returns look exceptional, but the comparison is arguably flattered by its near-zero-debt, buyback-heavy capital structure.
Current Ratio Drifts Toward One
Manhattan Associates' current ratio slipped from 1.31 in 2025Q3 to 1.07 in 2026Q3, having briefly touched 0.98 in 2026Q2, with quick ratio tracking identical figures that reflect negligible inventory, per the reported quarterly balance sheet ratios.
Because the quick ratio equals the current ratio in every period, liquidity rests entirely on receivables and cash, with no inventory buffer either to monetize or to strain under stress; at a 73-day DSO, a collection slowdown would transmit directly into the 1.07 cushion. The compression appears to coincide with the elevated repurchase cadence that consumed essentially all $845.2M of ten-quarter free cash flow, so the near-term buffer looks deliberately managed rather than operationally impaired. Offsetting this, deferred revenue of $348.1M (up 34.4% over ten quarters) represents contracted work whose delivery obligation is operational rather than a near-term cash call, though investors should still treat the thin current ratio as a narrower shock absorber than MANH's reputation for balance-sheet conservatism implies.
Debt Remains Tactical, Not Structural
D/E of 0.26 and D/EBITDA of 0.63 in 2026Q3 compare with 0.36 and 1.64 in 2025Q4, indicating leverage is used opportunistically rather than carried; interest coverage is unavailable in the supplied data, and refinancing risk appears remote based on reported figures.
Total debt of $51.7M in 2026Q3, down from $112.4M in 2025Q4, alongside D/EBITDA below 0.8x in nine of ten quarters, suggests borrowings functioned as a short-term funding bridge for repurchases rather than as structural capital structure. With interest coverage not disclosed in the provided series, the comfort of debt service cannot be directly gauged, so the assessment of leverage rests on the absolute debt quantum relative to free cash flow generation. The more relevant constraint appears to be equity, which fell 16.6% to $200.7M as liabilities grew 29.5%, meaning the balance sheet's resilience increasingly depends on continued cash generation rather than on the size of the capital base.
Asset Turnover Improves as Receivables Stretch
Asset turnover climbed from 0.34 in 2025Q4 to 0.42 in 2026Q3 while DSO lengthened to 73 days from 67 days in 2024Q3, suggesting revenue is growing faster than assets even as collections slow, according to the supplied ratio series.
The turnover improvement is directionally encouraging for a business where total assets grew only 12.9% over ten quarters against accelerating revenue, yet the DSO drift from 67 to 73 days hints that larger, implementation-heavy platform deals may be stretching payment terms rather than reflecting pure demand strength. DPO has stayed in a tight 16–20 day band (18 days in 2026Q3), which offers little supplier-side float and means any working-capital release must come from the receivable side; DIO and CCC are unavailable in this series, so a complete cash conversion cycle cannot be computed. Analysts should watch whether DSO stabilizes as the cloud subscription mix rises, since recurring billing typically shortens collection periods and would confirm that the current receivable build is transitional.
P/E Obscures the SBC and Mix Distortion
The trailing P/E of 65.0x is the ratio most commonly misapplied to Manhattan Associates, since stock compensation of $34.2M equaled 56% of 2026Q3 net income of $61.3M, materially flattering per-share economics as reported in the quarterly statements.
Because stock compensation is added back in full to operating cash flow while being expensed in net income, the same period simultaneously shows an apparently rich trailing P/E and a seemingly superior P/FCF of 37.0x, so neither multiple cleanly reflects the recurring economic cost of compensating consultants and engineers. The more informative framing appears to be EV/Sales of 12.8x read alongside deferred revenue growth of 34.4% and RPO direction, which captures contracted demand without the earnings noise created by the license-to-subscription revenue trough and lumpy services recognition. Investors should also avoid benchmarking the ~57% gross margin directly against pure-SaaS peers, since the services-inclusive mix structurally depresses the figure and makes margin comparisons misleading without stripping out the professional services line.